Hot Stocks in Afternoon Trading: AH, AVID, CRUS, ZLTQ, HW, AMRS

Wall Street signStocks are trading flat today as investors are opting to wait before making any big bets until the Fed and the ECB announce their decisions later this week. There was some positive economic data today as consumer confidence and home prices both saw improvements in July.

Apple Inc. (NASDAQ:AAPL) rose above $600 today on reports the company is considering a stock split which would allow the stock to be added to the Dow Jones Industrial Average.

The major stock averages are mixed this afternoon with the Dow down 20 points, the Nasdaq up 4 points and the S&P 500 down 2 points. [Read more...]

Active Stocks in Midday Trading: ASTM, ZLTQ, ANN, USU, DYN, HEK

stock market todayAastrom Biosciences, Inc. (NASDAQ:ASTM) is up 20.88% today at $2.20. ASTM has traded 2.7 million shares so far today, more than 10 times its average volume. ASTM shares are up today after the company completed $40 million in financing. The company has a market cap of 86.54 million.

Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ) is up 14.13% in midday trading at $6.46. ZLTQ has traded 770 thousand shares so far today, 3 times its average volume. Canaccord Genuity initiated coverage on Zeltiq today and gave it a buy rating. The company has a market cap of 219.33 million. [Read more...]

7 NASDAQ Stocks Stumbling This Morning: DNDN, SIGM, ZLTQ, FSYS, SMTC, DSCO, GMCR

NasdaqStocks are trading higher this morning thanks to optimism that Greece will complete its debt swap deal. Investors seemed to ignore the slightly negative jobless data today as weekly claims jumped 8,000 last week to 362,000. Economists were expecting claims to remain at 351,000. The major stock indices have given up some of their early gains, but remain positive right now. The Dow is up 40 points, the Nasdaq is up 17 points and the S&P 500 is up 7 points.

Dendreon Corporation (NASDAQ:DNDN) is down 14.90% this morning at $9.25. DNDN has traded 13.1 million shares so far today, 3 million shares more than its daily average. DNDN shares are taking a hit today after its rival Johnson & Johnson’s prostate drug beats placebo in trial. The company has a market cap of 1.35 billion. [Read more...]

Real Time Web Analytics